Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pediatr Transplant. 2010 Dec;14(8):968-75. doi: 10.1111/j.1399-3046.2010.01409.x. Epub 2010 Oct 5.

Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.

Author information

  • 1SickKids Transplant Centre, Department of Pediatrics, The Hospital for Sick Children and University of Toronto Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada. s.pollock.barziv@utoronto.ca

Abstract

  Late graft rejection impairs the long-term function of organ transplants in children. Previous studies suggest patients with wide variation in tacrolimus levels may have higher rates of late kidney and liver graft rejection. The reproducibility of this finding and impact on graft and recipient survival have not been reported. We investigated factors associated with late rejection > 6 months post-transplant in 144 heart, kidney, liver, and lung transplant recipients (ages 8-18, ≥ 1-yr survivors, receiving tacrolimus-based immunosuppression), comparing late rejectors (n = 61, 42%) to non-rejectors (no rejection > 6 months); groups had similar mean tacrolimus concentrations ≤ 6 months post-transplant. For all organ types, increased standard deviation in intrapatient tacrolimus blood levels was an independent risk factor for late rejection (OR 1.6 [CI 1.1-2.1]; p = 0.02). Each 1-point increase in s.d. > 2 of tacrolimus level > 6 months post-transplant associated with 1.58 increase in hazard of graft loss (p = 0.003). Graft survival (conditional on one-yr survival) was significantly better for those with s.d. < 2 at > 6 months post-transplant: 98% at three and five yr, versus 88%, 70%, at three and five yr, in patients with s.d. > 2 (p = 0.003). In conclusion, high s.d. in serial tacrolimus concentrations associated with increased risk of late rejection and graft loss in pediatric organ transplant recipients, providing opportunities for screening and interventions.

© 2010 John Wiley & Sons A/S.

PMID:
21040278
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk